Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Third Quarter 2024 Harvard Biosciences Inc. Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Harvey Partners Jeffrey Moskowitz | 2,715,000 | $7,303,350 | +7% | 0.83% |
2. | Royce & Associates Chuck Royce | 1,451,450 | $3,904,401 | +1% | 0.03% |
3. | Meros Investment Management Timothy Chatard | 833,589 | $2,242,354 | -1% | 1.01% |
4. | Renaissance Technologies Jim Simons | 724,078 | $1,947,770 | -3% | 0% |
5. | Citadel Investment Group Ken Griffin | 115,994 | $312,024 | -8% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.91 | 10,000 | Officer, Director | 3,111,091 | 2024-06-13 | Filing | |
$3.07 | 20,000 | Officer, Director | 3,101,091 | 2024-06-06 | Filing | |
$4.38 | 25,000 | Officer, Director | 2,862,679 | 2023-08-17 | Filing | |
$2.62 | 16,192 | Director | 202,485 | 2023-03-15 | Filing | |
$2.67 | 13,808 | Director | 186,293 | 2023-03-14 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$8.02 | 48,175 | Officer, Director | 2,091,725 | 2021-08-23 | Filing | |
$7.14 | 24,312 | Officer, Director | 2,279,778 | 2021-05-21 | Filing | |
$7.03 | 14,876 | Officer, Director | 2,279,778 | 2021-05-20 | Filing | |
$7.17 | 39,188 | Officer, Director | 2,279,778 | 2021-05-19 | Filing | |
$7.41 | 39,188 | Officer, Director | 2,279,788 | 2021-05-18 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 2,918,034 | $15,611,482 | 0.91% | |
2. | 2,913,814 | $15,588,905 | 0% | |
3. | 2,162,893 | $11,571,478 | 10.39% | |
4. | 2,102,571 | $11,248,755 | 0% | |
5. | 1,925,635 | $10,302,329 | 0% |